Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-017005
Filing Date
2025-02-25
Accepted
2025-02-25 17:44:25
Documents
2
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm257585-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm257585-1_3seq1.xml 3 1592
2 EXHIBIT 24 tm257585d1_ex24.htm EX-24 8326
  Complete submission text file 0001104659-25-017005.txt   11548
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 840 PARK AVE HOBOKEN NJ 07030
Business Address
Durso Jerome Benedict (Reporting) CIK: 0001698665 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 25665171